Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.
Human Enteric Glia Diversity in Health and Disease: New Avenues for the Treatment of Hirschsprung Disease.
Windster JD. et al, (2024), Gastroenterology
Goblet cell differentiation subgroups in colorectal cancer.
Abdullayeva G. et al, (2024), Proceedings of the National Academy of Sciences of the United States of America, 121
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource
Kapizioni C. et al, (2024), Journal of Crohn's and Colitis, 18, 790 - 800
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study.
Chanchlani N. et al, (2024), The lancet. Gastroenterology & hepatology, 9, 521 - 538
Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis
Gupta T. et al, (2024), Cancer Cell, 42, 797 - 814.e15
Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients
Bai BYH. et al, (2024), Journal of Crohn's and Colitis, 18, 431 - 445
GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis.
Rana N. et al, (2024), Cell, 187, 1011 - 1015
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis
Baumdick ME. et al, (2023), Gastroenterology, 165, 946 - 962.e13
A robust deep learning workflow to predict CD8 + T-cell epitopes
Lee CH. et al, (2023), Genome Medicine, 15
A Roadmap for the Human Gut Cell Atlas
Zilbauer M. et al, (2023), Nature Reviews Gastroenterology & Hepatology, 20, 597 - 614
Anti-TNF Biologicals Enhance the Anti-Inflammatory Properties of IgG N-Glycome in Crohn’s Disease
Hanić M. et al, (2023), Biomolecules, 13, 954 - 954
A systems approach evaluating the impact of SARS-CoV-2 variant of concern mutations on CD8+ T cell responses
Buckley PR. et al, (2023), Immunotherapy Advances, 3
Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
Cheung VTF. et al, (2020), British Journal of Cancer
Inflammatory Bowel Disease Through the Lens of Single-cell RNA-seq Technologies.
Corridoni D. et al, (2020), Inflammatory bowel diseases
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.
Serra EG. et al, (2020), Nature communications, 11
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.
Sazonovs A. et al, (2020), Gastroenterology, 158, 189 - 199
Immune checkpoint inhibitor-related colitis assessment and prognosis: can inflammatory bowel disease scoring point the way?
Cheung VTF. et al, (2020), JOURNAL OF CROHNS & COLITIS, 14, S286 - S288
Remission of Inflammatory Bowel Disease in Glucose-6-Phosphatase 3 Deficiency by Allogeneic Haematopoietic Stem Cell Transplantation
Bolton C. et al, (2020), Journal of Crohn's and Colitis, 14, 142 - 147
R-spondin 3 promotes stem cell recovery and epithelial regeneration in the colon
Harnack C. et al, (2019), Nature Communications, 10